Contraception · Oral Contraceptives
Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women
Spitzer WO, Lewis MA, Heinemann LA, Thorogood M, MacRae KD
Cite this paper
Spitzer, W. O., Lewis, M. A., Heinemann, L. A., Thorogood, M., & MacRae, K. D. (1996). Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ (Clinical Research Ed.), 312(7023), 83-88. https://doi.org/10.1136/bmj.312.7023.83
Spitzer WO, Lewis MA, Heinemann LA, Thorogood M, MacRae KD. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ. 1996;312(7023):83-88. doi:10.1136/bmj.312.7023.83
Spitzer, W. O., et al. "Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women." BMJ (Clinical Research Ed.), vol. 312, no. 7023, 1996, pp. 83-88.
For EndNote, Zotero or Mendeley:
Open access
Free to read
No reuse license
Open Access
Free full text on PubMed Central (PMC2349742)


